Article info
PDFInflammatory bowel disease
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn’s disease
- Correspondence to:
Dr P Rutgeerts
Department of Internal Medicine, UZ Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium; paul.rutgeerts{at}uz.kuleuven.ac.be
Citation
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn’s disease
Publication history
- Accepted January 3, 2007
- Revised December 29, 2006
- First published January 17, 2007.
Online issue publication
August 14, 2007
Article Versions
- Previous version (17 January 2007).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by Gut